Albemarle Co. (ALB) Shares Sold by Chase Investment Counsel Corp

Chase Investment Counsel Corp decreased its position in Albemarle Co. (NYSE:ALB) by 3.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 33,394 shares of the specialty chemicals company’s stock after selling 1,280 shares during the quarter. Albemarle makes up 2.3% of Chase Investment Counsel Corp’s portfolio, making the stock its 17th biggest holding. Chase Investment Counsel Corp’s holdings in Albemarle were worth $4,270,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the business. Bank of New York Mellon Corp grew its position in shares of Albemarle by 258.1% during the third quarter. Bank of New York Mellon Corp now owns 4,561,987 shares of the specialty chemicals company’s stock worth $621,845,000 after purchasing an additional 3,287,989 shares in the last quarter. Jennison Associates LLC grew its position in shares of Albemarle by 21.4% during the third quarter. Jennison Associates LLC now owns 7,797,076 shares of the specialty chemicals company’s stock worth $1,062,819,000 after purchasing an additional 1,375,546 shares in the last quarter. Janus Henderson Group PLC grew its position in shares of Albemarle by 95.3% during the third quarter. Janus Henderson Group PLC now owns 1,595,684 shares of the specialty chemicals company’s stock worth $217,507,000 after purchasing an additional 778,649 shares in the last quarter. Allianz Asset Management GmbH grew its position in shares of Albemarle by 98.8% during the third quarter. Allianz Asset Management GmbH now owns 1,307,904 shares of the specialty chemicals company’s stock worth $178,281,000 after purchasing an additional 650,158 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its position in shares of Albemarle by 113.6% during the third quarter. JPMorgan Chase & Co. now owns 975,732 shares of the specialty chemicals company’s stock worth $129,109,000 after purchasing an additional 518,990 shares in the last quarter. 87.38% of the stock is currently owned by institutional investors.

Several analysts recently issued reports on the company. Seaport Global Securities reiterated a “hold” rating and set a $130.00 target price on shares of Albemarle in a research report on Monday, February 5th. UBS Group increased their target price on Albemarle from $123.00 to $150.00 and gave the stock a “neutral” rating in a research report on Thursday, November 9th. Royal Bank of Canada reiterated a “buy” rating and set a $149.00 target price on shares of Albemarle in a research report on Wednesday, October 18th. Jefferies Group increased their target price on Albemarle from $156.00 to $162.00 and gave the stock a “buy” rating in a research report on Tuesday, November 14th. Finally, Robert W. Baird reiterated a “hold” rating and set a $135.00 target price on shares of Albemarle in a research report on Wednesday, November 1st. Ten analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $127.88.

Shares of Albemarle Co. (NYSE:ALB) traded up $1.80 during trading on Wednesday, hitting $110.25. The stock had a trading volume of 561,893 shares, compared to its average volume of 2,314,484. The stock has a market cap of $11,860.00, a PE ratio of 39.23, a price-to-earnings-growth ratio of 1.47 and a beta of 1.56. The company has a current ratio of 2.11, a quick ratio of 1.56 and a debt-to-equity ratio of 0.35. Albemarle Co. has a 12-month low of $91.02 and a 12-month high of $144.99.

COPYRIGHT VIOLATION WARNING: “Albemarle Co. (ALB) Shares Sold by Chase Investment Counsel Corp” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/14/albemarle-co-alb-holdings-decreased-by-chase-investment-counsel-corp.html.

About Albemarle

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply